Published in Acta Neuropathol on June 17, 2011
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell (2014) 2.57
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol (2011) 2.53
The clinical implications of medulloblastoma subgroups. Nat Rev Neurol (2012) 2.12
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics. Genes Dev (2012) 1.64
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. Nat Med (2014) 1.11
Molecular subgroups of medulloblastoma. Expert Rev Neurother (2012) 1.05
Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human molecular subgroups. Proc Natl Acad Sci U S A (2013) 0.95
Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathol (2012) 0.92
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model. Mol Cell Biol (2012) 0.91
Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors. Biol Sex Differ (2012) 0.90
Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy. Dev Cell (2016) 0.90
Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy. Expert Rev Mol Med (2015) 0.87
Deep sequencing identifies IDH1 R132S mutation in adult medulloblastoma. J Clin Oncol (2014) 0.87
Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors. F1000Prime Rep (2014) 0.86
The miR-183∼96∼182 cluster promotes tumorigenesis in a mouse model of medulloblastoma. J Biomed Res (2013) 0.83
Targeted treatment for sonic hedgehog-dependent medulloblastoma. Neuro Oncol (2014) 0.83
In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model. Neoplasia (2014) 0.82
Molecular markers in pediatric neuro-oncology. Neuro Oncol (2012) 0.81
Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol (2013) 0.81
Genetic and molecular alterations across medulloblastoma subgroups. J Mol Med (Berl) (2015) 0.81
Update on molecular and genetic alterations in adult medulloblastoma. Memo (2012) 0.80
Deregulated proliferation and differentiation in brain tumors. Cell Tissue Res (2014) 0.80
Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity. Cancer Res (2014) 0.80
Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup. Biomark Res (2015) 0.79
Molecular Classification of Medulloblastoma. Neurol Med Chir (Tokyo) (2016) 0.79
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes. Oncotarget (2015) 0.78
Medulloblastoma: molecular pathways and histopathological classification. Arch Med Sci (2016) 0.77
EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. J Neurooncol (2014) 0.77
Effect of small nuclear ribonucleoprotein-associated polypeptide N on the proliferation of medulloblastoma cells. Mol Med Rep (2015) 0.77
The Role of Hedgehog Signaling in Tumor Induced Bone Disease. Cancers (Basel) (2015) 0.77
Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors. Acta Neuropathol (2014) 0.76
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation. Nat Commun (2016) 0.76
Genetic grouping of medulloblastomas by representative markers in pathologic diagnosis. Transl Oncol (2013) 0.76
Medulloblastoma biology in the post-genomic era. Future Oncol (2012) 0.76
Actionable molecular biomarkers in primary brain tumors. Trends Cancer (2016) 0.75
The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma. Mol Brain (2015) 0.75
Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids. PLoS One (2016) 0.75
Medulloblastoma: Molecular Classification-Based Personal Therapeutics. Neurotherapeutics (2017) 0.75
Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery. Surg Neurol Int (2016) 0.75
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397). Am J Clin Oncol (2016) 0.75
Medulloblastoma in adults: they're not just big kids. Neuro Oncol (2016) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 10.99
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell (2006) 10.06
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol (2008) 8.23
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol (2008) 7.79
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Medulloblastoma growth inhibition by hedgehog pathway blockade. Science (2002) 6.53
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell (2006) 6.15
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86
Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Altered telomeres in tumors with ATRX and DAXX mutations. Science (2011) 4.60
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol (2010) 4.48
Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One (2008) 4.37
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol (2012) 4.00
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest (2008) 3.98
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res (2006) 3.81
Mutations in SUFU predispose to medulloblastoma. Nat Genet (2002) 3.78
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70
Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol (2006) 3.68
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol (2011) 3.66
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res (2005) 3.63
Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol (2010) 3.51
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47
NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (2010) 3.42
Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal (2010) 3.35
Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science (2013) 3.33
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol (2011) 3.33
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol (2014) 3.21
Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov (2013) 3.11